Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) -4.11M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 600
Avg Vol 1,408
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 37%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's lead medical device NELL-1/DBM, an osteopromotive recombinant protein that provides target-specific control over bone regeneration. It also develops NELL-1/DBM fusion device used in lumbar spinal fusion. The company's NELL-1 platform technology used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthoped...

Phone: 781 552 4452
Address:
2 Burlington Woods Drive, Suite 100, Burlington, United States
Latest News on BBLGW
No data available.